Haleon CEO Brian McNamara says his company is not as exposed as peers to tariff risks, as the consumer healthcare company ...
Haleon PLC HLN shares slipped 3.31% to £3.82 Thursday, on what proved to be an all-around favorable trading session for the ...
British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted to the second half ...
Haleon posted £11.23B in FY24 revenue, with 5% organic growth. 2025 guidance expects 4-6% organic growth, with profit gains ...
HALEON PLC (LON:HLN) shares slid 3% in London on Thursday after the Sensodyne toothpaste maker said its revenue growth for 2025 would be weighted toward the second half of the year.
Q4 2024 Earnings Conference Call February 27, 2025 4:00 AM ETCompany ParticipantsJo Russell - Head-Investor RelationsBrian McNamara ...
Unilever’s new CEO may want to awaken animal spirits at the seller of Dove soap and Axe deodorant. On Tuesday, the $139 ...
Find insight on AstraZeneca, Haleon and more in the latest Market Talks covering the health care sector.
Sensodyne-maker Haleon’s annual profits rose in line with expectations last year as it got a boost in demand for its oral ...
Haleon PLC closed 0.94% below its 52-week high of £4.01, which the company achieved on September 18th.
European markets are heading for a sharply lower open after President Donald Trump on Wednesday threatened to impose 25% ...
For 2025 Haleon expects organic revenue growth of 4% to 6%, organic operating profit growth ahead of organic revenue growth with both likely to be weighted towards the second half of the year. The ...